Vascular comorbidities seem to pose a risk factor for worse outcomes with COVID-19 [108]. Stroke is emerging as an increasingly important adverse event in COVID-19 patients. From a retrospective single-center study in China (n = 221), risk factors for stroke in COVID-19 patients appear to be: older age, more severe COVID-19, history of hypertension, diabetes, cerebrovascular diseases, and any marked inflammatory or pro-coagulant response, such as a high C-reactive protein or D-dimer level [108]. Cerebrovascular conditions may present as neurological symptoms in COVID-19 patients [21].